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Borderline personality disorder (BPD) is common in clinical practice. Psychotherapy is the 
treatment of choice, and Mentalization-based treatment (MBT) is one of the empirically 
supported treatments that are currently available. For adults, two variants of MBT (MBT day 
hospital (MBT-DH) and MBT intensive outpatient (MBT-IOP)) have been developed and 
empirically evaluated. In this paper, we will present a review of research of development, 
efficacy, and implementation of MBT. We first discuss evidence on the effectiveness of 
MBT-DH and MBT-IOP, the lack of comparative research, as well as the lack of research on 
predictors of treatment response. Next, we go on to discuss research suggesting that the 
dissemination and implementation of MBT for adolescents is hindered by the reluctance of 
clinicians to diagnose BPD in adolescence. As a result, there is a dearth of evidence-based 
treatments for adolescents, including MBT, although the recent increase in studies in this area 
suggests that this trend may be changing. Finally, we focus on the implementation of 
treatment programs for BPD patients. Although we now have different effective treatments 
for BPD, the implementation of these treatments in routine clinical practice has proven to be 
much more complex than initially thought. In addition, treatments such as MBT are multi-
modal, long-term treatments. Both societal pressures to increase the cost-effectiveness of our 
treatments, and new theoretical insights into the role of social learning and salutogenesis in 
the development of BPD, force us to reconsider some of our assumptions concerning the 






Borderline personality disorder 
Borderline personality disorder (BPD) is quite common in clinical practice (Leichsenring, 
Leibing, Kruse, & Leweke, 2011; Soeteman, Verheul, & Busschbach, 2008). Prevalence rates 
range from 3% in the general population to 10% in an outpatient setting (Trull, Jahng, Tomko, 
Wood, & Sher, 2008; Zimmerman, Chelminsky, & Young, 2008). BPD is associated with a 
broad range of problems, including co-morbid psychiatric disorders (Laurenssen et al., 
2014a), self-destructive behaviour (Paris, 2000), severe impairments in daily functioning 
(Bateman & Fonagy, 2004), a low quality of life (Soeteman et al., 2008), and high societal 
costs (Soeteman, Hakkaart-van Roijen, Verheul, & Busschbach, 2008). Psychotherapy is the 
treatment of choice for patients with BPD (Leichsenring, Leibing, Kruse, & Leweke, 2011; 
Soeteman, Verheul, & Busschbach, 2008). Different empirically supported treatments are 
currently available for adults and are recommended by treatment guidelines (American 
Psychiatric Association, 2001; Landelijke Stuurgroep Multidisciplinaire 
Richtlijnontwikkeling in de GGZ, 2008; National Institute for Health and Clinical Excellence, 
2009). These include Dialectical behaviour therapy (DBT: Linehan, 1993), Schema focused 
therapy (SFT: Young, Klosko, & Weishaar, 2003), Transference focused therapy (TFP: 
Clarkin, Yeomans, & Kernberg, 1999), Systems training for emotional predictability and 
problem solving (STEPPS: Blum, Bartels, St. John, & Pfohl, 2002), and Mentalization-based 
treatment (MBT: Bateman & Fonagy, 2004, 2006, 2012).  
 
Different variants of MBT have been developed and empirically evaluated. In this paper, we 
will present a review of research of development, efficacy, and implementation of MBT. We 
then will discuss new theoretical insights that force us to reconsider assumptions concerning 
the nature of treatment for individuals with BPD.  
 
Mentalization-based treatment 
BPD is characterized by impulsivity, and instability in affects, relationships, and identity. 
Bateman and Fonagy (2004) have related these problems to severe impairments in 
mentalizing capacities. Mentalizing can be defined as “the ability to understand actions by 
both other people and oneself in terms of thoughts, feelings, wishes, and desires” (Bateman & 
Fonagy, 2016, p.3).  
MBT was first developed in the United Kingdom by Bateman and Fonagy (2004, 2006, 2012, 
2016). It has its roots in attachment theory and contemporary social neuroscience. The main 
goal of MBT is to improve the mentalizing capacities of patients with BPD, especially within 
everyday interpersonal interactions. Two types of MBT have been developed and empirically 
evaluated for adults with BPD: MBT day hospital (MBT-DH) (Bateman & Fonagy, 1999, 
2001, 2008) and intensive outpatient MBT (MBT-IOP) (Bateman & Fonagy, 2009). The main 
goals of both variants of MBT are 1) engagement in therapy, 2) reduction of psychiatric 
symptoms, 3) improvement of self- and interpersonal functioning, 4) decrease in number of 
self-destructive acts and suicide attempts, and 5) improvement in social and occupational 
functioning. To achieve these goals, all treatment components focus on the enhancement of 
the patient‟s mentalizing capacity. Both types of MBT are also quite structured, and involve 
different tasks, aims and strategies in the different phases of treatment, ranging from a pre-
treatment, main treatment and follow up treatment phase (see Table 1), in order to ensure that 
treatment is delivered in a consistent, coherent and continuous way  (Bateman & Fonagy, 
2016). 
 
MBT-DH was first compared with standard psychiatric care in a randomized controlled trial 
(Bateman & Fonagy, 1999). MBT-DH was superior to standard psychiatric care in terms of 
reduction in depressive symptoms, suicidal and parasuicidal behaviour, hospitalization days, 
and improvement in social and interpersonal functioning. Two follow-up studies showed that 
these results were maintained at 18 months (Bateman & Fonagy, 2001) and 8 years (Bateman 
& Fonagy, 2008) follow-up. Health care costs were similar for both groups during treatment, 
but after treatment the MBT-DH group showed substantially lower costs (Bateman & Fonagy, 
2003).  
MBT-IOP, in turn, was compared with structured clinical management in a randomized 
controlled trial (Bateman & Fonagy, 2009). In both groups, improvements were found  in 
terms of parasuicidal behaviour, self-reported psychiatric symptoms, social and interpersonal 
functioning and medication use. Patients treated with MBT-IOP however, showed a stronger 
decrease of symptoms, including suicidal behaviour and hospitalization, particularly at long-
term follow-up.  
Our group conducted a naturalistic study (Bales et al., 2012) which showed that MBT-DH 
was associated with improvements in level of symptom distress, personality pathology, and 
social and interpersonal functioning. Effect sizes were moderate to large, comparable to and 
sometimes even higher than the effect sizes in the original UK trial (Bateman & Fonagy, 
1999). Furthermore, a reduction of parasuicidal behaviour was observed.  In another study, we 
(Bales et al., 2015) showed that patients in MBT-DH showed greater benefits than patients 
who received other specialized psychotherapies for personality disordered patients. Jorgensen 
and colleagues (2013), in turn, compared MBT-IOP with supportive psychotherapy. In this 
study, no differences were found between both conditions, which may, however, have 
resulted from potential spill-over effects as the same therapists offered both treatments.  
Although these findings suggest that both MBT-DH and MBT-IOP may be effective in the 
treatment of severe BPD, it is not clear whether both treatments are equally effective, nor 
whether some patients may benefit more from MBT-DH or MBT-IOP. In response, we set up 
a trial directly comparing the efficacy of both treatments. As these treatments also differ 
considerably in terms of intensity and frequency, a detailed economic analysis focusing on the 
cost-effectiveness of both treatment programmes is a key focus of this trial (Laurenssen et al., 
2014) (see Table 1). Finally, this study also aims to investigate potential differential treatment 
response as a function of pre-treatment patient characteristics. Results of this study will thus 
inform both cost-effectiveness considerations as well as the potential importance of treatment 
tailoring. 
 
-> insert Table 1 
 
Borderline personality disorder in adolescents 
Our group has also been involved in the development and evaluation of MBT for adolescents 
with marked personality pathology. Yet, the development, dissemination and implementation 
of MBT for this age group is hindered by at least three factors. First, because of the fear for 
stigmatization, the supposed changeability of personality at this age, and difficulty to 
distinguish between normal and abnormal personality, clinicians are often still reluctant to 
diagnose BPD in adolescents (Allertz & van Voorst, 2007; Chanen & McCutcheon, 2008). 
Research, however, shows that the reliability and validity of the diagnosis of BPD in 
adolescence is comparable to that in adulthood (Chanen, Jovev, McCutcheon, Jackson, & 
McGorry, 2008; Kaess, Brunner, & Chanen, 2014; Miller, Muehlenkamp, & Jacobson, 2008; 
Westen, DeFife, Malone, & DiLallo, 2014).  
There is now broad consensus that diagnosing BPD in adolescents is important and valid 
(Fonagy et al., 2015; Landelijk Kenniscentrum Kinder- en Jeugdpsychiatrie, 2011; National 
Institute for Health and Clinical Excellence, 2009). PDs are quite common in adolescents 
(Feenstra, Busschbach, Verheul, & Hutsebaut, 2011; Grilo et al., 1998; Westen, Shedler, 
Durett, Glass, & Martens, 2003) and are associated with a higher burden of disease than in 
any other life phase. PDs in adolescents are associated with more painful affects (Bradley, 
Zittel Conklin, & Westen, 2005), more self-destructive and suicidal behaviour (Claes & 
Vandereycken, 2007; Lewinsohn, Rohde, & Seeley, 1996), and high societal costs (Cailhol et 
al., 2012; Feenstra et al., 2012). These findings, however, have trouble finding their way into 
clinical practice (Laurenssen, Hutsebaut, Feenstra, Luyten, & Busschbach, 2013).  
Second, until recently, there was relatively little known about the potential role of 
impairments in mentalizing, a central focus of MBT, in adolescence. However, over the last 
decade, there is an increasing number of both theoretical and empirical studies that have 
begun to address this gap (Fonagy & Luyten, 2016; Rossouw & Fonagy, 2012; Sharp & Kim, 
2015). 
Third, despite the high unmet needs for treatment of adolescents with BPD, and the fact that 
adolescence is a key period to intervene because of the flexibility of BPD traits in this life 
phase (Chanen & McCutcheon, 2013), there is a dearth of evidence-based treatments for 
adolescents with BPD, including MBT. In a randomized controlled trial, Chanen and 
colleagues (2008) compared Cognitive analytic therapy (CAT) with good clinical care. No 
significant differences were found, however, between the two groups, although there was 
some evidence suggested that the CAT group improved more rapidly. Schuppert and 
colleagues (2009, 2012) investigated the effects of an Emotion regulation training (ERT) in a 
randomized controlled trial as compared to TAU. Patients in both treatment groups improved 
equally, while patients in the ERT group showed a significant increase in internal locus of 
control. Finally, a number of studies suggest that Dialectical behaviour therapy (DBT: 
Linehan, 1993) is associated with a reduction in the need for hospitalization, attrition, and 
behavioural incidents for adolescents with BPD symptoms (MacPherson, Cheavens, & 
Fristad, 2013; Mehlum et al., 2014), however more research is needed with adequate 
randomization and follow up (Fonagy et al., 2015).  
 
Mentalization-based treatment for adolescents 
As for MBT for adolescents, different adaptations have been described. Bleiberg (2001) 
described a treatment approach based on MBT principles based on developmental- and 
attachment theory specifically. Asen and Bevington (2007) developed AMBIT (Adolescent 
Mentalization Based Integrative Therapy) for the „hard to reach‟ adolescents, a flexible team-
based outreach approach. In a randomized controlled trial, Rossouw and Fonagy (2012) 
compared outpatient MBT for adolescents with TAU in adolescents with self-harm. In this 
study, 73% of the adolescents met DSM-IV criteria for BPD. MBT was found to be superior 
to TAU in terms of reductions in self-harm and depressive symptoms. Bo and colleagues 
(2016) investigated a Mentalization-based group therapy for adolescents with BPD. They 
found that the majority of the adolescents showed improvements in terms of reduction of BPD 
symptoms, depression and general psychopathology. An interesting finding in their study is 
that adolescents with enhanced trust in peers and parents in combination with improvements 
in mentalizing capacities showed more reduction of BPD symptoms.  In a small pilot-study, 
Laurenssen and colleagues (2014b) investigated inpatient MBT for adolescents. Promising 
results were found, with a decrease in level of symptom severity and improvements in 
personality functioning and quality of life. However, there were marked problems with the 
implementation of this treatment (Hutsebaut, Bales, Busschbach, & Verheul, 2012), which 
has led to the development of an adapted outpatient MBT program for adolescents, which is 
currently investigated in a pilot-trial (see Table 2) 
 
As is the case for adults, very little is known about the optimal treatment length and frequency 
in MBT for adolescents, nor is much known about the potential of treatment tailoring. Little is 
known about predictors, beyond the fact that MBT may be particularly indicated in more 
severe patients (Bateman & Fonagy, 2013). And although implementation problems 
associated with inpatient MBT (as for instance expressed in high levels of acting out and 
burn-out in therapists), suggest that outpatient treatment may be associated with better 
outcomes, there is currently no empirical support for this assumption. Likewise, less intensive 
(i.e., outpatient) and outreaching interventions may be most effective in adolescents, as it 
maximizes their opportunities for social learning and provides the least disruption to the 
normative developmental challenges they face. Again, however, empirical evidence in this 
area is largely lacking, and there may be a subgroup of adolescents for which intensive, 
inpatient and/or step-down programmes may be indicated.  
 
-> insert Table 2 
 
Implementation of MBT 
Another neglected issue in research on MBT concerns implementation issues. While MBT 
may have shown to be effective in well-controlled studies, it remains to be seen whether it can 
be effectively implemented in routine clinical care. A recent study in The Netherlands, for 
example, showed that only 23% of the patients diagnosed with BPD received specialized 
psychotherapy such as MBT (Hermens, van Splunteren, van den Bosch, & Verheul, 2011). 
Furthermore, as noted, the evidence in support of evidence-based treatments is often obtained 
in controlled conditions, typically in randomized controlled trials. It is less clear whether these 
results can be maintained in less optimal conditions typical for clinical practice. Several 
studies suggest that dissemination of evidence-based treatments, and particularly of more 
complex lengthy treatment such as BPD, leads to less beneficial outcomes (Durlak & DuPre, 
2008; Shoenwald, 2008). This has been shown, for example, for multi-systemic therapy for 
youngsters with behavioural problems (Henggeler, 2004).  
The outcome of psychotherapy may be strongly related to the organizational context in which 
the treatment model is delivered; and this may be particularly the case in treating patients with 
complex psychopathology, such as BPD (Bateman & Krawitz, 2013).  
Indeed, studies suggest that the implementation of treatment models for patients with BPD is 
a complex process, with risks in relation to both effectiveness as well as safety, for both staff 
and patients (Hutsebaut, Bales, Verheul, & Busschbach, 2012). We were first alerted to the 
importance of implementation issues in the context of a study on the implementation of MBT 
for adolescents (MBT-A). In this study, we serendipitously found that problems with the 
implementation of MBT-A depended on problems at three levels of implementation: at the 
organizational level (i.e., organizational structures, institutional culture, staffing, logistics and 
budget planning), the team level (i.e., team culture, leadership, team communication), and at 
the level of individual team members (i.e., personal selection, experience and knowledge). 
Implementation studies of other therapeutic modalities for BPD, such as DBT and SFT, have 
come to similar conclusions (Nadort et al., 2009; van den Bosch & Sinnaeve, 2015).  
This study and subsequent experiences with the implementation of MBT, have led to the 
development of a quality manual for MBT, in which these three levels are described and 
discussed in detail. Also, specific recommendations for the successful implementation of 
MBT are made  (Bateman, Bales, & Hutsebaut, 2013). Currently, we are in the process of 
systematically studying the influence of these three levels on the implementation of MBT in 
routine clinical practice. For instance, in a quasi-experimental study by our research group 
(Bales et al., submitted), we showed that the effect sizes of poorly implemented MBT for 
adults with BPD were only half and at long-term follow-up even a third of successfully 
implemented MBT. Hence, if replicated, these findings suggest that there is a clear need for 
strategies to monitor and adjust conditions under which MBT may be an effective treatment 
for BPD.  
 
Does intensity and frequency matter? 
The assumption that more severely disturbed patients require the most intensive treatment, 
seems no longer justified (Bateman & Fonagy, 2016). Together with societal pressures, this 
forces us to reconsider the role of issues of frequency and intensity and the relationship 
between both.  
Recent theoretical conceptualizations, rooted in contemporary evolutionary biology and 
developmental psychopathology, provide an interesting perspective on this issue in our 
opinion. Specifically, Fonagy and Luyten (2015) have proposed a new conceptualization of 
mechanisms of change in the treatment of patients with BPD, which has immediate 
implications for issues related to treatment frequency and intensity. They suggest that change 
in psychotherapy, and in the treatment of BPD in particular, involves three systems or sets of 
processes. The first system relates to the extent to which the patient feels validated and 
understood by the theoretical understanding of his or her condition that is conveyed upon him.  
All evidence-based treatment models provide a framework, in which the patient can examine 
important issues. A model of the mind is offered in a coherent way, which enables the patient 
to feel understood (Communication system 1: the teaching and learning of content). By 
experiencing that the therapist is seeking to understand the patient‟s perspective, patients can 
learn to hear and to listen (Communication system 2: the re-emergence of robust mentalizing). 
Hence, the experience of feeling thought about sets the patient in a learning mode: he or she 
becomes (again) open to communication and thus to change. Indeed, rigidity, defined lacking 
the capacity to be open to new information conveyed by others, is a hallmark of BPD. Yet, the 
re-emergence of mentalizing is not the mechanism behind change in this new approach. For 
true change to happen, the patient has to change the way how he or she feels and thinks about 
the (social) world, which is ultimately also shown in changes in behaviour. This, however, 
also implies that the extent to which a patient might benefit from any given treatment will also 
be determined by the social world of that patient (Communication system 3: the re-emergence 
of social learning beyond therapy). Although patients may actively contribute to a changing 
environment (as is for instance shown in patients ending specific relationships and seeking out 
other people and contexts in this phase of the treatment), often there are serious limitations to 
patients ability and possibilities to bring about change in their environment. This necessarily 
implies that treatment should explicitly focus on the social environment of the patient, and 
thus the length and intensity of treatment may also be dependent on the quality of the social 
environment of the patient.  
  
Conclusions  
Different variants of MBT for both adults as well as adolescents have been developed and 
empirically evaluated. However, the question of “what works for whom” also remains largely 
elusive in this domain. In our opinion, research is needed investigating which patients might 
benefit more from the more intensive forms of treatment and which patients will benefit more 
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Table 1: Comparing MBT-DH and MBT-IOP 
 MBT-DH MBT-IOP 
Pre- 
treatment 
Focus on engaging the patient in treatment and crisis management 
Introductory course (MBT-i) 
Biweekly individual sessions with a focus on crisis planning 
Main 
treatment 
18 months (maximum), 5 days 18 months (maximum) 
Group psychotherapy (daily) 
Individual psychotherapy (weekly) 
Individual crisis planning (on 
indication) 
Art therapy (twice a week) 
Writing therapy (weekly) 
Mentalizing cognitive group therapy 
(weekly) 
Social hour and community meeting 
Medication consults (on indication) 
Group psychotherapy (twice a week) 
Individual psychotherapy (weekly) 
Individual crisis planning (on 
indication) 
Medication consults (on indication) 
Follow up 
treatment 
Individual tailored stepped down care, aiming at relapse prevention, 
maintaining the gains made in mentalizing capacities 
 
  
Table 2: Components of MBT for adolescents 
Pre-treatment Focus on engaging the patient in treatment and crisis 
management 
Introductory course (MBT-i)  
Introductory course for parents (MBT-i) 
Biweekly individual sessions with a focus on crisis planning 
Family sessions (monthly) 
Main treatment 12 months 
Group psychotherapy (weekly) 
Individual psychotherapy (weekly) 
Individual crisis planning (on indication) 
Family sessions (biweekly) 
Medication consults (on indication) 
Follow up treatment Individual tailored stepped down care, aiming at relapse 
prevention, maintaining the gains made in mentalizing capacities 
 
